Author

S. A. Coggins

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

B. Kim· 2 shared A. C. Fries· 1 shared A. Cormier· 1 shared A. E. Eakin· 1 shared A. Ganesan· 1 shared A. Saib· 1 shared A. Schwab· 1 shared A. Siddiqui· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

S. Lusvarghi, S. D. Pollett, S. N. Neerukonda, W. Wang, R. Wang, R. Vassell, N. J. Epsi, A. C. Fries, B. K. Agan, D. A. Lindholm, C. J. Colombo, R. Mody, E. C. Ewers, T. Lalani, A. Ganesan, , C. D. Weiss

A third dose of Pfizer/BioNTech vaccine significantly boosts Omicron neutralizing antibodies, while convalescent sera and therapeutic antibodies show variable and often low neutralization.

bioRxiv · Dec 22, 2021Microbiology

SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells

C. Martinat, A. Cormier, J. Tobaly-Tapiero, N. Palmic, N. Casartelli, S. A. Coggins, J. Buchrieser, M. Persaud, F. Diaz-Griffero, L. Espert, G. Bossis, P. Lesage, O. Schwartz, B. Kim, F. Margottin, , A. Zamborlini

This study shows that SUMOylation of SAMHD1 at K595 is necessary for its antiviral activity in non-cycling cells, independent of its dNTPase function.

bioRxiv · Jun 4, 2020Microbiology

Thymidylate synthase maintains the de-differentiated state of aggressive breast cancers

A. Siddiqui, P. N. Gollavilli, A. Schwab, M. E. Vazakidou, P. Ersan, M. Ramakrishnan, D. Pluim, S. A. Coggins, O. Saatci, L. Annaratone, J. H. Schellens, B. Kim, I. A. Asangani, S. A. K. Rasheed, C. Marchio, , P. Ceppi

This study shows that thymidylate synthase promotes de-differentiation in aggressive breast cancers by supporting pyrimidine catabolism and EMT, correlating with poor prognosis.

Cell Death & Differentiation · Nov 1, 2019Peer-reviewedCancer Biology